ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676317; 2) Community: the network communities that were significantly associated with the response to NSC 676317; 3) Molecule: the relationships between components within communities and NSC 676317; 4) MDR: the compounds that were significantly associated with the NSC 676317.

NSC Compound Enrichment Correlation
NSC 100880 Camptothecin 0.0126882509540134 0.12655145
NSC 105014 Cladribine 0.0126882509540134 0.18540955
NSC 18805 .gamma.-Thujaplicine 0.0126882509540134 0.022739667
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0126882509540134 -0.0417391
NSC 300289 Pinafide 0.0126882509540134 0.23237973
NSC 349622 Cytovaricin 0.0126882509540134 0.20321031
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0126882509540134 0.34195438
NSC 603071 Aminocamptothecin 0.0126882509540134 0.19453006
NSC 606497 Camptothecin Derivative 0.0126882509540134 0.17903212
NSC 608329 Null 0.0126882509540134 -0.22685995
Total:95  Current:25    [First] [Prev] [Next] [Last]